Skip to main content

Advertisement

SpringerLink
Log in

Pelvic applications of MR-guided high intensity focused ultrasound

  • Published:
Abdominal Imaging Aims and scope Submit manuscript

Abstract

MR-guided high intensity focused ultrasound (MRg HIFU) is a novel method of tissue ablation that incorporates high energy focused ultrasound for tissue heating and necrosis within an MR scanner that provides simultaneous stereotactic tissue targeting and thermometry. To date, MRg HIFU has been used primarily to treat uterine fibroids, but many additional applications in the pelvis are in development. This article reviews the basic technology of MRg HIFU, and the use of MRg HIFU to treat uterine fibroids, adenomyosis, and prostate cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Dobrotwir A, Pun E (2012) Clinical 24 month experience of the first MRgFUS unit for treatment of uterine fibroids in Australia. J Med Imaging Radiat Oncol 56:409–416

    Article  PubMed  Google Scholar 

  2. Lindstrom PA (1954) Prefrontal ultrasonic irradiation: a substitute for lobotomy. AMA Arch Neurol Psychiatry 72:399–425

    Article  PubMed  CAS  Google Scholar 

  3. Ren XL, Zhou XD, Yan RL, et al. (2009) Sonographically guided extracorporeal ablation of uterine fibroids with high-intensity focused ultrasound: midterm results. J Ultrasound Med 28:100–103

    PubMed  Google Scholar 

  4. Tsakiris P, Thüroff S, de la Rosette J, Chaussy C (2008) Transrectal high-intensity focused ultrasound devices: a critical appraisal of the available evidence. J Endourol 22:221–229

    Article  PubMed  Google Scholar 

  5. Okolo S (2008) Incidence, aetiology and epidemiology of uterine fibroids. Best Pract Res Clin Obstet Gynaecol 22:571–588

    Article  PubMed  Google Scholar 

  6. Marshall LM, Spiegelman D, Barbieri RL, et al. (1997) Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol 90:967–973

    Article  PubMed  CAS  Google Scholar 

  7. Jacoby VL, Autry A, Jacobson G, et al. (2009) Nationwide use of laparoscopic hysterectomy compared with abdominal and vaginal approaches. Obstet Gynecol 114:1041–1048

    Article  PubMed  Google Scholar 

  8. http://www.alternativesurgeryblog.com/sexual-dysfunction-with-hysterectomy/. Accessed 28 Jan 2013

  9. Mokate T, Wright C, Mander T (2006) Hysterectomy and sexual function. Menopause Int 12:153–157

    Google Scholar 

  10. Altman D, Granath F, Cnattingius S, Falconer C (2007) Hysterectomy and risk of stress-urinary-incontinence surgery: nationwide cohort study. Lancet 370:1494–1499

    Article  PubMed  Google Scholar 

  11. Walker WJ, Pelage JP (2002) Uterine artery embolisation for symptomatic fibroids: clinical results in 400 women with imaging follow up. BJOG 109:1262–1272

    Article  PubMed  CAS  Google Scholar 

  12. Harding G, Coyne KS, Thompson CL, Spies JB (2008) The responsiveness of the uterine fibroid symptom and health-related quality of life questionnaire (UFS-QOL). Health Qual Life Outcomes 6:99

    Article  PubMed  Google Scholar 

  13. Stewart EA, Gostout B, Rabinovici J, et al. (2007) Sustained relief of leiomyoma symptoms by using focused ultrasound surgery. Obstet Gynecol 110:279–287

    Article  PubMed  Google Scholar 

  14. Wyatt KM, Dimmock PW, Walker TJ, O’Brien PM (2001) Determination of total menstrual blood loss. Fertil Steril 76:125–131

    Article  PubMed  CAS  Google Scholar 

  15. http://www.accessdata.fda.gov/cdrh_docs/pdf4/P040003b.pdf. Accessed 28 Jan 2013

  16. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=20708. Accessed 28 Jan 2013

  17. Pistofidis G, Makrakis E, Balinakos P, et al. (2012) Report of 7 uterine rupture cases after laparoscopic myomectomy: update of the literature. J Minim Invasive Gynecol 19:762–767

    Article  PubMed  Google Scholar 

  18. Pitter MC, Gargiulo AR, Bonaventura LM, Lehman JS, Srouji SS (2013) Pregnancy outcomes following robot-assisted myomectomy. Hum Reprod 28:99–108

    Article  PubMed  Google Scholar 

  19. Rabinovici J, David M, Fukunishi H, et al. (2010) Pregnancy outcome after magnetic resonance-guided focused ultrasound surgery (MRgFUS) for conservative treatment of uterine fibroids. Fertil Steril 93:199–209

    Article  PubMed  Google Scholar 

  20. http://www.clinicaltrials.gov/ct2/show/NCT00730886. Accessed 28 Jan 2013

  21. Lénárd ZM, McDannold NJ, Fennessy FM, et al. (2008) Uterine leiomyomas: MR imaging-guided focused ultrasound surgery–imaging predictors of success. Radiology 249:187–194

    Article  PubMed  Google Scholar 

  22. deSouza NM, Williams AD (2002) Uterine arterial embolization for leiomyomas: perfusion and volume changes at MR imaging and relation to clinical outcome. Radiology 222:367–374

    Google Scholar 

  23. Stewart EA, Rabinovici J, Tempany CM, et al. (2006) Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril 85:22–29

    Article  PubMed  Google Scholar 

  24. Judson O (2010) Enhancing the placebo. Op-Ed column. New York Times, May 4, 2010. http://www.nytimes.com/2010/05/04/opinion/04judson.html. Accessed 5 March 2011

  25. Sanket D, Bero L, Redberg R, et al. (2009) Strength of study evidence examined by the FDA in premarket approval of cardiovascular devices. JAMA 302:2679–2685

    Article  Google Scholar 

  26. http://clinicaltrials.gov/ct2/show/NCT00656305?term=mrgfus&rank=7. Accessed 5 March 2011

  27. Bodenheimer T (2000) Uneasy alliance–clinical investigators and the pharmaceutical industry. N Engl J Med 342:1539–1544

    Article  PubMed  CAS  Google Scholar 

  28. Angell M (2008) Industry-sponsored clinical research: a broken system. JAMA 300:1069–1071

    Article  PubMed  CAS  Google Scholar 

  29. Steinbrook R (2009) Controlling conflict of interest—proposals from the institute of medicine. N Engl J Med 360:2160–2163

    Article  PubMed  CAS  Google Scholar 

  30. Jacoby V, Jacoby A, Kohi M, et al. (2012) MR guided focused ultrasound for uterine fibroids: a pilot randomized placebo controlled trial. In: Current and future applications of focused ultrasound 2012, 3rd International Symposium, Program Book. p 44

  31. Yoo EH, Lee PI, Huh CY, et al. (2007) Predictors of leiomyoma recurrence after laparoscopic myomectomy. J Minim Invasive Gynecol 14:690–697

    Article  PubMed  Google Scholar 

  32. Hanafi M (2005) Predictors of leiomyoma recurrence after myomectomy. Obstet Gynecol 105:877–881

    Article  PubMed  Google Scholar 

  33. Funaki K, Fukunishi H, Sawada K (2009) Clinical outcomes of magnetic resonance-guided focused ultrasound surgery for uterine myomas: 24-month follow-up. Ultrasound Obstet Gynecol 34:584–589

    Article  PubMed  CAS  Google Scholar 

  34. Spies J, Bruno J, Czeyda-Pommersheim F, et al. (2005) Long-term outcome of uterine artery embolization of leiomyomas. Obstet Gynecol 106:933–939

    Article  PubMed  Google Scholar 

  35. Katsumori T, Kasahara T, Akazawa K (2006) Long-term outcomes of uterine artery embolization using gelatin sponge particles alone for symptomatic fibroids. AJR Am J Roentgenol 186:848–854

    Article  PubMed  Google Scholar 

  36. Ruuskanen A, Sipola P, Hippeläinen M, Wüstefeld M, Manninen H (2009) Pain after uterine fibroid embolisation is associated with the severity of myometrial ischaemia on magnetic resonance imaging. Eur Radiol 19:2977–2985

    Article  PubMed  Google Scholar 

  37. Kim KA, Yoon SW, Yoon BS, et al. (2011) Spontaneous vaginal expulsion of uterine myoma after magnetic resonance-guided focused ultrasound surgery. J Minim Invasive Gynecol 18:131–134

    Article  PubMed  Google Scholar 

  38. Radeleff B, Eiers M, Bellemann N, et al. (2010) Expulsion of dominant submucosal fibroids after uterine artery embolization. Eur J Radiol 75:e57–e63

    Article  PubMed  Google Scholar 

  39. http://lawmedconsultant.com/385/recent-large-malpractice-verdicts/. Accessed 28 Jan 2013

  40. Cockerham AZ (2012) Adenomyosis: a challenge in clinical gynecology. J Midwifery Womens Health 57:212–220

    Article  PubMed  Google Scholar 

  41. Vercellini P, Vigano P, Somigliana E, et al. (2006) Adenomyosis: epidemiological factors. Best Pract Res Clin Obstet Gynecol 20:465–477

    Article  Google Scholar 

  42. Fan TY, Zhang L, Chen W, et al. (2012) Feasibility of MRI-guided high intensity focused ultrasound treatment for adenomyosis. Eur J Radiol 81:3624–3630

    Article  PubMed  Google Scholar 

  43. Fukunishi H, Funaki K, Yamaguchi K, Sawada K (2011) Two-year outcome of MRgFUS treatment of adenomyosis. Poster at 21st World Congress of the International Society of Ultrasound in Obstetrics and Gynecology, 2011

  44. Kim MD, Kim S, Kim NK, et al. (2007) Long-term results of uterine artery embolization for symptomatic adenomyosis. AJR Am J Roentgenol 188:176–181

    Article  PubMed  Google Scholar 

  45. Stamey TA, McNeal JE (1992) Adenocarcinoma of the prostate. In: Walsh PC, Retik AB, Stamey TA, Vaughan ED (eds) Campbell’s urology, vol. 2, 6th edn. Philadelphia: WB Saunders, pp 1159–1221

    Google Scholar 

  46. Epstein JI, Walsh PC, Carmichael M, Brendler CB (1994) Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 271:368–374

    Article  PubMed  CAS  Google Scholar 

  47. Carter HB, Sauvageot J, Walsh PC, Epstein JI (1997) Prospective evaluation of men with stage T1C adenocarcinoma of the prostate. J Urol 157:2206–2209

    Article  PubMed  CAS  Google Scholar 

  48. Eggener SE, Mueller A, Berglund RK, et al. (2013) A multi-institutional evaluation of active surveillance for low risk prostate cancer. J Urol 189(1 Suppl):S19–S25

    Article  PubMed  Google Scholar 

  49. Ahmed HU, Moore C, Emberton M (2009) Minimally-invasive technologies in uro-oncology: the role of cryotherapy, HIFU and photodynamic therapy in whole gland and focal therapy of localised prostate cancer. Surg Oncol 18:219–232

    Article  PubMed  Google Scholar 

  50. Marberger M, Carroll PR, Zelefsky MJ, et al. (2008) New treatments for localized prostate cancer. Urology 72(6 Suppl):S36–S43

    Article  PubMed  Google Scholar 

  51. Polascik TJ, Mouraviev V (2008) Focal therapy for prostate cancer. Curr Opin Urol 18:269–274

    Article  PubMed  Google Scholar 

  52. Shelley M, Wilt TJ, Coles B, Mason MD (2007) Cryotherapy for localised prostate cancer. Cochrane Database Syst Rev 18:CD005010

    Google Scholar 

  53. Barqawi AB, Crawford ED (2007) The current use and future trends of focal surgical therapy in the management of localized prostate cancer. Cancer J 13:313–317

    Article  PubMed  Google Scholar 

  54. Muto S, Yoshii T, Saito K, et al. (2008) Focal therapy with high-intensity-focused ultrasound in the treatment of localized prostate cancer. Jpn J Clin Oncol 38:192–199

    Article  PubMed  Google Scholar 

  55. Ahmed HU, Emberton M (2008) Active surveillance and radical therapy in prostate cancer: can focal therapy offer the middle way? World J Urol 26:457–467

    Article  PubMed  Google Scholar 

  56. Miller DC, Sanda MG, Dunn RL, et al. (2005) Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J Clin Oncol 23:2772–2780

    Article  PubMed  Google Scholar 

  57. Barocas DA, Cowan JE, Smith JAJr, Carroll PR, CaPSURE Investigators (2008) What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database. J Urol 180:1330–1334

    Article  PubMed  Google Scholar 

  58. Schröder FH, Hugosson J, Roobol MJ, et al. (2009) Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360:1320–1328

    Article  PubMed  Google Scholar 

  59. Andriole GL, Crawford ED, Grubb RL III, et al. (2009) Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360:1310–1319

    Article  PubMed  CAS  Google Scholar 

  60. Sanghvi NT, Foster RS, Bihrle R, et al. (1999) Noninvasive surgery of prostate tissue by high intensity focused ultrasound: an updated report. Eur J Ultrasound 9:19–29

    Article  PubMed  CAS  Google Scholar 

  61. Lee HM, Hong JH, Choi HY (2006) High-intensity focused ultrasound therapy for clinically localized prostate cancer. Prostate Cancer Prostatic Dis 9:439–443

    Article  PubMed  CAS  Google Scholar 

  62. Blana A, Walter B, Rogenhofer S, Wieland WF (2004) High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience. Urology 63:297–300

    Article  PubMed  Google Scholar 

  63. Vallancien G, Prapotnich D, Cathelineau X, Baumert H, Rozet F (2004) Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localized prostate cancer: feasibility study. J Urol 171(6 Pt 1):2265–2267

    Article  PubMed  Google Scholar 

  64. Ficarra V, Antoniolli SZ, Novara G, et al. (2006) Short-term outcome after high-intensity focused ultrasound in the treatment of patients with high-risk prostate cancer. BJU Int 98:1193–1198

    Article  PubMed  Google Scholar 

  65. Han KR, Cohen JK, Miller RJ, et al. (2003) Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience. J Urol 170(4 Pt 1):1126–1130

    Article  PubMed  Google Scholar 

  66. Mouraviev V, Mayes JM, Polascik TJ (2009) Pathologic basis of focal therapy for early-stage prostate cancer. Nat Rev Urol 6:205–215

    Article  PubMed  Google Scholar 

  67. Jayram G, Eggener SE (2009) Patient selection for focal therapy of localized prostate cancer. Curr Opin Urol 19:268–273

    Article  PubMed  Google Scholar 

  68. Scheidler J, Hricak H, Vigneron DB, et al. (1999) Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging–clinicopathologic study. Radiology 213:473–480

    PubMed  CAS  Google Scholar 

  69. Yu KK, Scheidler J, Hricak H, et al. (1999) Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology 213:481–488

    PubMed  CAS  Google Scholar 

  70. Coakley FV, Kurhanewicz J, Lu Y, et al. (2002) Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. Radiology 223:91–97

    Article  PubMed  Google Scholar 

  71. Chang S, Westphalen A, Jha P, et al. (2011) Endorectal MRI and MR spectroscopic imaging of prostate cancer: developing selection criteria for MR-guided focused ultrasound surgery-preliminary experience. American Roentgen Ray Society Annual Program. p 33

  72. Anwar MM, Westphalen AC, Jung A, et al. (2012) Role of endorectal MRI and MRSI in defining the dominant intraprostatic lesion in prostate cancer: quantitative analysis of imaging contour compared to whole-mount histopathology. Int J Radiat Oncol Biol Phys 84:S403

    Article  Google Scholar 

  73. Yerram N, Hoang A, Partanen A, et al. (2012) MR-guided trans-urethral prostate HIFU in a preclinical model. Mid Atlantic Section of the American Urological Association 2012 Annual Meeting Abstract. http://meeting.maaua.org/abstracts/2012/MP24.cgi. Accessed 11 April 2013

  74. Kinsey AM, Diederich CJ, Rieke V, et al. (2008) Transurethral ultrasound applicators with dynamic multi-sector control for prostate thermal therapy: in vivo evaluation under MR guidance. Med Phys 35:2081–2093

    Article  PubMed  Google Scholar 

  75. Zini C, Hipp E, Thomas S, et al. (2012) Ultrasound- and MR-guided focused ultrasound surgery for prostate cancer. World J Radiol 4:247–252

    Article  PubMed  Google Scholar 

  76. Falk MH, Issels RD (2001) Hyperthermia in oncology. Int J Hyperthermia 17:1–18

    Article  PubMed  CAS  Google Scholar 

  77. Mukhopadhaya A, Mendecki J, Dong X, et al. (2007) Localized hyperthermia combined with intratumoral dendritic cells induces systemic antitumor immunity. Cancer Res 67:7798–7806

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Diagnostic Radiology, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Mail Code: L340, Portland, OR, 97239, USA

    Fergus V. Coakley & Bryan R. Foster

  2. Dotter Interventional Institute, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Mail Code: L340, Portland, OR, 97239, USA

    Khashayar Farsad

  3. Department of Radiation Oncology, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Mail Code: L340, Portland, OR, 97239, USA

    Arthur Y. Hung

  4. Department of Urology, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Mail Code: L340, Portland, OR, 97239, USA

    Christopher L. Amling

  5. Department of Obstetrics and Gynecology, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Mail Code: L340, Portland, OR, 97239, USA

    Kathleen J. Wilder & Aaron B. Caughey

Authors
  1. Fergus V. Coakley
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bryan R. Foster
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Khashayar Farsad
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Arthur Y. Hung
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kathleen J. Wilder
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Christopher L. Amling
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Aaron B. Caughey
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fergus V. Coakley.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Coakley, F.V., Foster, B.R., Farsad, K. et al. Pelvic applications of MR-guided high intensity focused ultrasound. Abdom Imaging 38, 1120–1129 (2013). https://doi.org/10.1007/s00261-013-9999-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-013-9999-2

Keywords

Search

Navigation